644 related articles for article (PubMed ID: 34070217)
1. Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease.
Serra M; Pinna A; Costa G; Usiello A; Pasqualetti M; Avallone L; Morelli M; Napolitano F
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070217
[No Abstract] [Full Text] [Related]
2. The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models.
Napolitano F; D'Angelo L; de Girolamo P; Avallone L; de Lange P; Usiello A
Neuroscience; 2018 Aug; 384():419-428. PubMed ID: 29857029
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia.
Brugnoli A; Napolitano F; Usiello A; Morari M
Neurobiol Dis; 2016 Jan; 85():155-163. PubMed ID: 26522958
[TBL] [Abstract][Full Text] [Related]
4. The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses.
Napolitano F; De Rosa A; Russo R; Di Maio A; Garofalo M; Federici M; Migliarini S; Ledonne A; Rizzo FR; Avallone L; Nuzzo T; Biagini T; Pasqualetti M; Mercuri NB; Mazza T; Chambery A; Usiello A
Sci Rep; 2019 Oct; 9(1):15294. PubMed ID: 31653935
[TBL] [Abstract][Full Text] [Related]
5. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons.
Errico F; Santini E; Migliarini S; Borgkvist A; Centonze D; Nasti V; Carta M; De Chiara V; Prosperetti C; Spano D; Herve D; Pasqualetti M; Di Lauro R; Fisone G; Usiello A
Mol Cell Neurosci; 2008 Feb; 37(2):335-45. PubMed ID: 18035555
[TBL] [Abstract][Full Text] [Related]
6. Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion.
Ghiglieri V; Napolitano F; Pelosi B; Schepisi C; Migliarini S; Di Maio A; Pendolino V; Mancini M; Sciamanna G; Vitucci D; Maddaloni G; Giampà C; Errico F; Nisticò R; Pasqualetti M; Picconi B; Usiello A
Sci Rep; 2015 Jul; 5():10933. PubMed ID: 26190541
[TBL] [Abstract][Full Text] [Related]
7. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
8. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
[TBL] [Abstract][Full Text] [Related]
9. Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age.
Costa G; Porceddu PF; Serra M; Casu MA; Schiano V; Napolitano F; Pinna A; Usiello A; Morelli M
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925704
[TBL] [Abstract][Full Text] [Related]
10. Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.
Sciamanna G; Napolitano F; Pelosi B; Bonsi P; Vitucci D; Nuzzo T; Punzo D; Ghiglieri V; Ponterio G; Pasqualetti M; Pisani A; Usiello A
Neurobiol Dis; 2015 Jun; 78():146-61. PubMed ID: 25818655
[TBL] [Abstract][Full Text] [Related]
11. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P
Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317
[TBL] [Abstract][Full Text] [Related]
12. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity.
Harrison LM; LaHoste GJ
Neuroscience; 2006; 137(2):483-92. PubMed ID: 16352400
[TBL] [Abstract][Full Text] [Related]
13. RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.
Shahani N; Swarnkar S; Giovinazzo V; Morgenweck J; Bohn LM; Scharager-Tapia C; Pascal B; Martinez-Acedo P; Khare K; Subramaniam S
Sci Signal; 2016 Nov; 9(454):ra111. PubMed ID: 27902448
[TBL] [Abstract][Full Text] [Related]
14. Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine?
Villalba RM; Smith Y
Neuroscience; 2013 Oct; 251():2-20. PubMed ID: 23867772
[TBL] [Abstract][Full Text] [Related]
15. The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging.
Pinna A; Napolitano F; Pelosi B; Di Maio A; Wardas J; Casu MA; Costa G; Migliarini S; Calabresi P; Pasqualetti M; Morelli M; Usiello A
Mov Disord; 2016 Apr; 31(4):583-9. PubMed ID: 26853527
[TBL] [Abstract][Full Text] [Related]
16. Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.
Subramaniam S; Napolitano F; Mealer RG; Kim S; Errico F; Barrow R; Shahani N; Tyagi R; Snyder SH; Usiello A
Nat Neurosci; 2011 Dec; 15(2):191-3. PubMed ID: 22179112
[TBL] [Abstract][Full Text] [Related]
17. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.
Hu ZL; Sun T; Lu M; Ding JH; Du RH; Hu G
Brain Behav Immun; 2019 Oct; 81():509-522. PubMed ID: 31288070
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
19. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.
Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H
J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596
[TBL] [Abstract][Full Text] [Related]
20. Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
Koski SK; Leino S; Panula P; Rannanpää S; Salminen O
Neurosci Lett; 2020 Jun; 729():134932. PubMed ID: 32224226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
